Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Cristiana Pistol Tanase, Monica Neagu, Radu Albulescu, Eleonora Codorean & Simona Olimpia Dima. (2009) Biomarkers in the diagnosis and early detection of pancreatic cancer. Expert Opinion on Medical Diagnostics 3:5, pages 533-546.
Read now
Read now
Cristiana Pistol Tanase. (2008) Caveolin-1: a marker for pancreatic cancer diagnosis. Expert Review of Molecular Diagnostics 8:4, pages 395-404.
Read now
Read now
Articles from other publishers (20)
Yingjie Wu, Shan Pan, Jun Leng, Tian Xie, Muhammad Jamal, Qian Yin, Jingyuan Li, Chunjiang He, Xin Dong, Liang Shao & Qiuping Zhang. (2019) The prognostic value of matrix metalloproteinase‐7 and matrix metalloproteinase‐15 in acute myeloid leukemia. Journal of Cellular Biochemistry 120:6, pages 10613-10624.
Crossref
Crossref
Yan Tang, Andong Shao, Jun Cao, Hui Li, Qiang Li, Meiying Zeng, Ming Liu, Yingsheng Cheng & Weihong Zhu. (2017) cNGR-based synergistic-targeted NIR fluorescent probe for tracing and bioimaging of pancreatic ductal adenocarcinoma. Science China Chemistry 61:2, pages 184-191.
Crossref
Crossref
Wei Peng & Airen Jiang. (2016) Long noncoding RNA CCDC26 as a potential predictor biomarker contributes to tumorigenesis in pancreatic cancer. Biomedicine & Pharmacotherapy 83, pages 712-717.
Crossref
Crossref
Steven T. Sizemore, Gina M. Sizemore, Christine N. Booth, Cheryl L. Thompson, Paula Silverman, Gurkan Bebek, Fadi W. Abdul-Karim, Stefanie Avril & Ruth A. Keri. (2014) Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors. Breast Cancer Research and Treatment 146:1, pages 25-40.
Crossref
Crossref
Shingo Kato, Kazunori Akimoto, Yoji Nagashima, Hitoshi Ishiguro, Kensuke Kubota, Noritoshi Kobayashi, Kunihiro Hosono, Seitaro Watanabe, Yusuke Sekino, Takamitsu Sato, Kazunori Sasaki, Noboru Nakaigawa, Yoshinobu Kubota, Yoshiaki Inayama, Itaru Endo, Shigeo Ohno, Shin Maeda & Atsushi Nakajima. (2013) aPKCλ/ι is a beneficial prognostic marker for pancreatic neoplasms. Pancreatology 13:4, pages 360-368.
Crossref
Crossref
Prawej Mahawithitwong, Kenoki Ohuchida, Naoki Ikenaga, Hayato Fujita, Ming Zhao, Shingo Kozono, Koji Shindo, Takao Ohtsuka, Kazuhiro Mizumoto & Masao Tanaka. (2013) Kindlin-2 Expression in Peritumoral Stroma Is Associated With Poor Prognosis in Pancreatic Ductal Adenocarcinoma. Pancreas 42:4, pages 663-669.
Crossref
Crossref
Giuseppe Aprile, Claudio Avellini, Michele Reni, Micol Mazzer, Luisa Foltran, Diego Rossi, Stefano Cereda, Emiliana Iaiza, Gianpiero Fasola & Andrea Piga. (2012) Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma. Tumor Biology 34:1, pages 131-137.
Crossref
Crossref
Junshuo Jin, Joon-Mee Kim, Yoon-Seok Hur, Won Pyo Cho, Keon-Young Lee, Seung-Ik Ahn, Kee Chun Hong & In-Sun Park. (2012) Clinical significance of clusterin expression in pancreatic adenocarcinoma. World Journal of Surgical Oncology 10:1.
Crossref
Crossref
Nobuyuki Yanagisawa, Masaaki Ichinoe, Tetuo Mikami, Norihiro Nakada, Kiyomi Hana, Wasaburo Koizumi, Hitoshi Endou & Isao Okayasu. (2012) High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas. Journal of Clinical Pathology 65:11, pages 1019-1023.
Crossref
Crossref
Wei Qu, Erik J. Tokar, Andrew J. Kim, Matthew W. Bell & Michael P. Waalkes. (2012)
Chronic Cadmium Exposure
in Vitro
Causes Acquisition of Multiple Tumor Cell Characteristics in Human Pancreatic Epithelial Cells
. Environmental Health Perspectives 120:9, pages 1265-1271.
Crossref
Crossref
Yuichi Nagao, Masanori Hisaoka, Atsuji Matsuyama, Shuichi Kanemitsu, Tetsuo Hamada, Tokihiko Fukuyama, Ryuji Nakano, Akihiko Uchiyama, Masahiko Kawamoto, Koji Yamaguchi & Hiroshi Hashimoto. (2012) Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma. Modern Pathology 25:1, pages 112-121.
Crossref
Crossref
Shingo Kato, Kensuke Kubota, Takeshi Shimamura, Yoshiyasu Shinohara, Noritoshi Kobayashi, Seitaro Watanabe, Masato Yoneda, Masahiko Inamori, Fumio Nakamura, Hitoshi Ishiguro, Noboru Nakaigawa, Yoji Nagashima, Masataka Taguri, Yoshinobu Kubota, Yoshio Goshima, Satoshi Morita, Itaru Endo, Shin Maeda, Atsushi Nakajima & Hitoshi Nakagama. (2011) Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer. Cancer Science 102:11, pages 2029-2037.
Crossref
Crossref
D Ansari, A Rosendahl, J Elebro & R Andersson. (2011) Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer. British Journal of Surgery 98:8, pages 1041-1055.
Crossref
Crossref
Jeran K. Stratford, David J. Bentrem, Judy M. Anderson, Cheng Fan, Keith A. Volmar, J. S. Marron, Elizabeth D. Routh, Laura S. Caskey, Jonathan C. Samuel, Channing J. Der, Leigh B. Thorne, Benjamin F. Calvo, Hong Jin Kim, Mark S. Talamonti, Christine A. Iacobuzio-Donahue, Michael A. Hollingsworth, Charles M. Perou & Jen Jen Yeh. (2010) A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma. PLoS Medicine 7:7, pages e1000307.
Crossref
Crossref
Yuri Miyazawa, Takamasa Uekita, Nobuyoshi Hiraoka, Satoko Fujii, Tomoo Kosuge, Yae Kanai, Yoshihisa Nojima & Ryuichi Sakai. (2010) CUB Domain–Containing Protein 1, a Prognostic Factor for Human Pancreatic Cancers, Promotes Cell Migration and Extracellular Matrix Degradation. Cancer Research 70:12, pages 5136-5146.
Crossref
Crossref
Jin-Hyeok Hwang, Johannes Voortman, Elisa Giovannetti, Seth M. Steinberg, Leticia G. Leon, Yong-Tae Kim, Niccola Funel, Joo Kyung Park, Min A. Kim, Gyeong Hoon Kang, Sun-Whe Kim, Marco Del Chiaro, Godefridus J. Peters & Giuseppe Giaccone. (2010) Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer. PLoS ONE 5:5, pages e10630.
Crossref
Crossref
Cristiana Pistol Tanase, Monica Neagu, Radu Albulescu & Mihail Eugen Hinescu. 2010.
145
180
.
Hugo Mendieta ZerónJesús Rey García FloresMartha Liliana Romero Prieto. (2009) Limitations in improving detection of pancreatic adenocarcinoma. Future Oncology 5:5, pages 657-668.
Crossref
Crossref
Jen Jen Yeh. (2009) Prognostic signature for pancreatic cancer: are we close?. Future Oncology 5:3, pages 313-321.
Crossref
Crossref
Mikiko Takikita, Sean Altekruse, Charles F. Lynch, Mark T. Goodman, Brenda Y. Hernandez, Mark Green, Wendy Cozen, Myles Cockburn, Maria Sibug Saber, Marie Topor, Chris Zeruto, Behnoush Abedi-Ardekani, Marsha E. Reichman & Stephen M. Hewitt. (2009) Associations between Selected Biomarkers and Prognosis in a Population-Based Pancreatic Cancer Tissue Microarray. Cancer Research 69:7, pages 2950-2955.
Crossref
Crossref